Giapreza Injection
Product Images NDC 68547-005

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Giapreza (NDC 68547-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by La Jolla Pharmaceutical Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1ml-vial-carton (1 mL Vial Carton)

Giapreza (angiotensin II) Injection is a prescription medication used for intravenous infusion. It contains 2.5mg angiotensin II with inactive ingredients including mannitol, water for injection, and sodium hydroxide. It is packaged in single-dose vials of 1mL and should be diluted before administration. It is necessary to discard any unused portion of the vial. The medication should be stored in refrigeration between 2°C and 8°C (36°F and 46°F). This product is manufactured by the La Jolla Pharmaceutical Company located in San Diego, California.*

FDA Label Image

1ml-vial (1 mL Vial)

This text seems to be a label or package insert for a medication called dx3 containing angiotensin acetate, which should be stored between 2°C-8°C, and is supplied as a single-dose vial. It also includes information about a specific NDC (68547-501-02) and a reference to discarding any unused portion. It is unclear what the purpose of the medication is or how it should be administered.*

FDA Label Image

Giapreza Forest Plot

FDA Label Image

Giapreza Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.